Gulf Pharmaceutical Industries PSC (JULPHAR):企業の財務・戦略的SWOT分析

◆英語タイトル:Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0999
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:UAE
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gulf Pharmaceutical Industries PSC (JULPHAR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa region. The company’s product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, cardiopulmonary care, gastro care and pain management and consumer care products. The company has manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia. Julphar has offices in Asia, Middle East and Africa and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Gulf Pharmaceutical Industries PSC Key Recent Developments

Nov 14,2019: Julphar reports financial results for Q3 2019
Oct 13,2019: Julphar appoints new Chief Finance & Strategy Officer
Jun 21,2019: Julphar bolsters management team with new senior appointments
Apr 18,2019: Julphar’s Chairman and Vice-Chairman step down
Apr 04,2019: Julphar to support Zimbabwe healthcare sector

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Gulf Pharmaceutical Industries PSC – Key Facts
Gulf Pharmaceutical Industries PSC – Key Employees
Gulf Pharmaceutical Industries PSC – Key Employee Biographies
Gulf Pharmaceutical Industries PSC – Major Products and Services
Gulf Pharmaceutical Industries PSC – History
Gulf Pharmaceutical Industries PSC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Gulf Pharmaceutical Industries PSC – Business Description
Gulf Pharmaceutical Industries PSC – SWOT Analysis
SWOT Analysis – Overview
Gulf Pharmaceutical Industries PSC – Strengths
Gulf Pharmaceutical Industries PSC – Weaknesses
Gulf Pharmaceutical Industries PSC – Opportunities
Gulf Pharmaceutical Industries PSC – Threats
Gulf Pharmaceutical Industries PSC – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 14, 2019: Julphar reports financial results for Q3 2019
Oct 13, 2019: Julphar appoints new Chief Finance & Strategy Officer
Jun 21, 2019: Julphar bolsters management team with new senior appointments
Apr 18, 2019: Julphar’s Chairman and Vice-Chairman step down
Apr 04, 2019: Julphar to support Zimbabwe healthcare sector
Feb 15, 2019: Julphar announces 2018 preliminary results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Gulf Pharmaceutical Industries PSC, Key Facts
Gulf Pharmaceutical Industries PSC, Key Employees
Gulf Pharmaceutical Industries PSC, Key Employee Biographies
Gulf Pharmaceutical Industries PSC, Major Products and Services
Gulf Pharmaceutical Industries PSC, History
Gulf Pharmaceutical Industries PSC, Subsidiaries
Gulf Pharmaceutical Industries PSC, Joint Venture
Gulf Pharmaceutical Industries PSC, Key Competitors
Gulf Pharmaceutical Industries PSC, Ratios based on current share price
Gulf Pharmaceutical Industries PSC, Annual Ratios
Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont...1)
Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont...2)
Gulf Pharmaceutical Industries PSC, Interim Ratios
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Gulf Pharmaceutical Industries PSC, Performance Chart (2014 - 2018)
Gulf Pharmaceutical Industries PSC, Ratio Charts
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Gulf Pharmaceutical Industries PSC (JULPHAR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arm Cement Plc:企業の戦略・SWOT・財務情報
    Arm Cement Plc - Strategy, SWOT and Corporate Finance Report Summary Arm Cement Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cap Gemini S.A.:戦略・SWOT・企業財務分析
    Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report Summary Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Varta AG (VAR1):企業の財務・戦略的SWOT分析
    Varta AG (VAR1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Trumpf GmbH + Co KG:企業の戦略的SWOT分析
    Trumpf GmbH + Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Max Delbruck Center for Molecular Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Max Delbruck Center for Molecular Medicine (MDC) is a biomedical research center that offers translating discoveries from molecular research into applications. The company’s research area services offer for cancer research, cardiovascular and metabolic disease, diseases of the nervous system …
  • Valio Ltd:企業の戦略的SWOT分析
    Valio Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Global Payments Inc.:企業の戦略・SWOT・財務分析
    Global Payments Inc. - Strategy, SWOT and Corporate Finance Report Summary Global Payments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Incyte Corp (INCY):企業の財務・戦略的SWOT分析
    Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • IHI Corporation:企業の戦略・SWOT・財務分析
    IHI Corporation - Strategy, SWOT and Corporate Finance Report Summary IHI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Safe Orthopaedics SA (SAFOR):企業の財務・戦略的SWOT分析
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Vaisala oyj (VAIAS):企業の財務・戦略的SWOT分析
    Summary Vaisala oyj (Vaisala) is a manufacturer of industrial and environmental measurement products. Its products include automatic weather stations and sensors, aviation weather systems, wireless temperature and humidity data loggers, indoor monitoring systems, weather radar products, rail weather …
  • Vindhya Telelinks Ltd:企業の戦略・SWOT・財務情報
    Vindhya Telelinks Ltd - Strategy, SWOT and Corporate Finance Report Summary Vindhya Telelinks Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • St.George Bank:企業の戦略的SWOT分析
    St.George Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Carbon Energy Corp (CRBO):石油・ガス:M&Aディール及び事業提携情報
    Summary Carbon Energy Corp (Carbon Energy), formerly Carbon Natural Gas Company is an independent oil and gas company. The company operates in the exploration, operation, management, and development of oil and gas properties in the Appalachian and Illinois Basin regions of the US. It holds interests …
  • NovImmune SA:製薬・医療:M&Aディール及び事業提携情報
    Summary NovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and ka …
  • Gateway Lifestyle Group:企業の戦略・SWOT・財務情報
    Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report Summary Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • miacom diagnostics GmbH-医療機器分野:企業M&A・提携分析
    Summary miacom diagnostics GmbH (miacom) is a molecular diagnostic company that develops and distributes molecular diagnostic tests. The company offers products such as hemoFISH, which identifies sepsis-related pathogens directly from positive blood culture bottles; respiFISH that identifies pathoge …
  • Proximus plc (PROX):企業の財務・戦略的SWOT分析
    Proximus plc (PROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • Cincinnati Bell Inc (CBB):企業の財務・戦略的SWOT分析
    Cincinnati Bell Inc (CBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆